Atlas Trials

N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

Clinical trial NCT01260649 · TERMINATED

Trial details

NCT number
NCT01260649
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2010-11-01
Primary completion
2012-10-26
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.